Nanoformulation of the PARP Inhibitor Olaparib Enables Radiosensitization of a Radiation-Resistant Prostate Cancer Model

Autor: Baldwin, P., Van De Ven, A.L., Seitzer, N., Clohessy, S., Cormack, R.A., Makrigiorgos, M., Pandolfi, P.P., Sridhar, S.
Zdroj: In International Journal of Radiation Oncology, Biology, Physics 1 October 2016 96(2) Supplement:E595-E595
Databáze: ScienceDirect